Sector Gamma As Gilead Sciences, Inc. Transaction History

Sector Gamma As

$339 Million
Q1 2024

A detailed history of Sector Gamma As transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sector Gamma As holds 265,619 shares of GILD stock, worth $18.2 Million. This represents 5.74% of its overall portfolio holdings.

Number of Shares

265,619

Previous 382,362 30.53%

Holding current value

$18.2 Million

Previous $31 Million 37.19%

% of portfolio

5.74%

Previous 7.88%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$71.58 - $87.29 $8.36 Million - $10.2 Million	-116,743 Reduced 30.53%	265,619 $19.5 Million
Q4 2023 Feb 05, 2024	SELL	$73.27 - $83.09 $17.6 Million - $20 Million	-240,761 Reduced 38.64%	382,362 $31 Million
Q3 2023 Nov 06, 2023	BUY	$73.94 - $80.67 $1.61 Million - $1.76 Million	21,756 Added 3.62%	623,123 $46.7 Million
Q2 2023 Aug 09, 2023	BUY	$76.01 - $86.7 $4.45 Million - $5.08 Million	58,594 Added 10.8%	601,367 $46.3 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $4.12 Million - $4.69 Million	-53,263 Reduced 8.94%	542,773 $45 Million

Q4 2022 Feb 07, 2023	SELL	$62.32 - $89.47 $17.9 Million - $25.7 Million	-287,070 Reduced 32.51%	596,036 $51.2 Million
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $2.36 Million - $2.7 Million	39,679 Added 4.7%	883,106 $54.5 Million
Q2 2022 Aug 05, 2022	BUY	$57.72 - $65.01 $9.34 Million - $10.5 Million	161,889 Added 23.75%	843,427 $52.1 Million
Q1 2022 May 06, 2022	BUY	$57.92 - $72.58 $22.3 Million - $27.9 Million	384,483 Added 129.43%	681,538 $40.5 Million
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $4.8 Million - $5.45 Million	-74,030 Reduced 19.95%	297,055 $21.6 Million
Q3 2021 Oct 29, 2021	SELL	$67.69 - $73.03 $14 Million - $15.1 Million	-206,283 Reduced 35.73%	371,085 $25.9 Million
Q2 2021 Aug 04, 2021	SELL	$63.47 - $69.35 $6.43 Million - $7.02 Million	-101,265 Reduced 14.92%	577,368 $39.8 Million
Q1 2021 May 10, 2021	SELL	$60.0 - $68.46 $9.57 Million - $10.9 Million	-159,507 Reduced 19.03%	678,633 $43.9 Million
Q4 2020 Feb 10, 2021	BUY	$56.65 - $64.55 $20.5 Million - $23.3 Million	361,046 Added 75.68%	838,140 $48.8 Million
Q3 2020 Nov 09, 2020	BUY	$62.1 - $78.08 $2.69 Million - $3.38 Million	43,310 Added 9.98%	477,094 $30.1 Million
Q2 2020 Aug 07, 2020	BUY	$72.34 - $84.0 $17 Million - $19.7 Million	234,365 Added 117.52%	433,784 $33.4 Million
Q1 2020 May 11, 2020	SELL	$62.63 - $80.22 $13.5 Million - $17.3 Million	-216,186 Reduced 52.02%	199,419 $14.9 Million
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $3.66 Million - $4.03 Million	-59,451 Reduced 12.51%	415,605 $27 Million
Q3 2019 Nov 05, 2019	BUY	$62.51 - $69.0 $1.88 Million - $2.07 Million	30,000 Added 6.74%	475,056 $30.1 Million
Q2 2019 Jul 31, 2019	SELL	$61.87 - $69.38 $8.27 Million - $9.27 Million	-133,681 Reduced 23.1%	445,056 $30.1 Million
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $9.03 Million - $10.1 Million	144,380 Added 33.24%	578,737 $37.6 Million
Q4 2018 Feb 12, 2019	BUY	$60.54 - $79.0 $6.73 Million - $8.78 Million	111,170 Added 34.4%	434,357 $27.2 Million
Q3 2018 Nov 15, 2018	BUY	$71.28 - $78.92 $9.77 Million - $10.8 Million	137,024 Added 73.6%	323,187 $25 Million
Q3 2018 Nov 08, 2018	SELL	$71.28 - $78.92 $7.52 Million - $8.32 Million	-105,437 Reduced 36.16%	186,163 $14.4 Million
Q2 2018 Aug 02, 2018	BUY	$64.88 - $75.68 $12.2 Million - $14.2 Million	188,100 Added 181.74%	291,600 $20.7 Million
Q1 2018 May 09, 2018	SELL	$72.84 - $88.8 $18.5 Million - $22.6 Million	-254,390 Reduced 71.08%	103,500 $7.8 Million
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $1.58 Million - $1.85 Million	22,200 Added 6.61%	357,890 $25.6 Million
Q3 2017 Nov 07, 2017	SELL	$72.11 - $85.47 $15.3 Million - $18.2 Million	-212,700 Reduced 38.79%	335,690 $27.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	548,390	548,390 $38.8 Million

Others Institutions Holding GILD

# of Institutions

1,884

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $86B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

News

Stay updated on Sector Gamma As with notifications on news.

Account